−65.0
RedHill Biopharma Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−29.2
FY23:
−35.8
FY24:
−9.37
FY25:
−9.65
Change from FY21 to FY25
millions USD
FY21:
−8.14
FY22:
8.30
FY23:
0.00
FY24:
−0.01
FY25:
1.69
Change from FY21 to FY25
millions USD
FY21:
73.5
FY22:
11.5
FY23:
21.4
FY24:
8.42
FY25:
7.32
millions USD
FY21:
0.28
FY22:
−9.43
FY23:
−14.4
FY24:
−0.96
FY25:
−0.64
(positive)
Change from FY21 to FY25
millions USD
FY21:
−65.2
FY22:
−29.4
FY23:
−35.8
FY24:
−9.38
FY25:
−9.66
All amounts in millions USD